Characterize multifaceted interactions between COVID-19 and alcohol use disorder based on real-time analysis of electronic health records of 62 million adult patients
Characterize multifaceted interactions between COVID-19 and alcohol use disorder based on real-time analysis of electronic health records of 62 million adult patients
批准号:
10377762
负责人:
Pamela B Davis
金额:
$36.23万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-22 至 2024-08-31
关键词:
18 year old2019-nCoVAdultAffectAgeAlcohol consumptionAlcoholsAmericanAnxietyAreaBehavioralBehavioral inhibitionBereavementBiologicalCOVID-19COVID-19 pandemicCOVID-19 patientCannabisCategoriesCenters for Disease Control and Prevention (U.S.)Cessation of lifeCocaineCognitiveComplexConsumptionCrowdingDatabasesDiagnosisEconomic BurdenElectronic Health RecordEvolutionFamilyFeeling suicidalFrequenciesFrightGeneral PopulationGrief reactionHeart DiseasesHeavy DrinkingHospitalizationHumanImpairmentIncomeInfectionInterventionInvestigationLeadMalignant NeoplasmsMeasuresMedicalMental DepressionMental HealthMental disordersNeuraxisNeurologicOpioidOrganismOutcomePatientsPost-Traumatic Stress DisordersPredispositionPrevalencePsyche structurePsychosesPublic HealthRiskRisk FactorsSARS-CoV-2 infectionSalesSchizophreniaSiteSocial isolationSubstance Use DisorderSurvivorsTestingTimeTobaccoUpdateVariantVirusVirus DiseasesWorkplacealcohol riskalcohol use disorderbasechronic liver diseasecomorbiditycoronavirus diseasecostdisorder riskgender disparityhigh riskpandemic diseasepreventracial disparityresponsesocialstimulant use disordersynergismtherapy designvaccine hesitancy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
During the pandemic, with social isolation and grief as drivers, alcohol consumption is increasing. SARS-CoV-2
itself has substantial impact on the central nervous system. When two such important public health menaces
intersect, it is crucial to understand their interaction and potential synergy. In this project titled “Characterize
multifaceted interactions between COVID-19 and alcohol use disorder based on real-time analysis of
electronic health records of 62 million adult patients”, we propose to: 1) characterize susceptibility to
COVID-19 in patients with alcohol use disorder (AUD) (“AUD → COVID-19”), consider racial and gender
disparity, and follow its evolution over time; 2) characterize how COVID-19 infection and the social pandemic
context impact the risk of AUD (“COVID-19 plus pandemic context → AUD”), consider racial and gender
disparity, and follow these changes over time; and 3) characterize prevalence of major psychiatric disorders,
other substance use disorders and severe outcomes among patients with both AUD and COVID-19
(“AUD+COVID-19 → outcomes”) and to follow these outcomes over time. Our studies will identify potential
areas for timely interventions to protect patients or mitigate the worst effects of COVID-19 pandemic and AUD,
singly and combined. This is especially important if there should be another surge with a virus variant, or if
vaccine hesitancy is greater in those with AUD. It will also inform such studies if we have another pandemic
with another organism, for the approaches we pioneer in these studies using nation-wide database of
electronic health records may pave the way for rapid, real-time analytics and results to inform our control
measures.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Collision of Alzheimers disease and COVID-19 pandemic in the United States: risks, outcomes, disparities and treatments
-
批准号:10417884
-
项目类别:
-
资助金额:$234.2万
-
财政年份:2022
-
负责人:Pamela B Davis
-
依托单位:
Characterize multifaceted interactions between COVID-19 and alcohol use disorder based on real-time analysis of electronic health records of 62 million adult patients
-
批准号:10687823
-
项目类别:
-
资助金额:$36.23万
-
财政年份:2021
-
负责人:Pamela B Davis
-
依托单位:
Characterize multifaceted interactions between COVID-19 and alcohol use disorder based on real-time analysis of electronic health records of 62 million adult patients
-
批准号:10491155
-
项目类别:
-
资助金额:$36.23万
-
财政年份:2021
-
负责人:Pamela B Davis
-
依托单位:
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
-
批准号:8366088
-
项目类别:
-
资助金额:$419.91万
-
财政年份:2011
-
负责人:Pamela B Davis
-
依托单位:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
-
批准号:8366086
-
项目类别:
-
资助金额:$169.96万
-
财政年份:2011
-
负责人:Pamela B Davis
-
依托单位:
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
-
批准号:8366087
-
项目类别:
-
资助金额:$139.97万
-
财政年份:2011
-
负责人:Pamela B Davis
-
依托单位:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
-
批准号:8366090
-
项目类别:
-
资助金额:$169.96万
-
财政年份:2011
-
负责人:Pamela B Davis
-
依托单位:
CASE WESTERN RESERVE UNIVERSITY/CLEVELAND CLINIC CTSA
-
批准号:8366089
-
项目类别:
-
资助金额:$233.28万
-
财政年份:2011
-
负责人:Pamela B Davis
-
依托单位:
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
-
批准号:8173797
-
项目类别:
-
资助金额:$428.07万
-
财政年份:2010
-
负责人:Pamela B Davis
-
依托单位:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
-
批准号:8173795
-
项目类别:
-
资助金额:$160.53万
-
财政年份:2010
-
负责人:Pamela B Davis
-
依托单位:
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
-
批准号:8173796
-
项目类别:
-
资助金额:$214.03万
-
财政年份:2010
-
负责人:Pamela B Davis
-
依托单位:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
-
批准号:8173799
-
项目类别:
-
资助金额:$160.53万
-
财政年份:2010
-
负责人:Pamela B Davis
-
依托单位:
CASE WESTERN RESERVE UNIVERSITY/CLEVELAND CLINIC CTSA
-
批准号:8173798
-
项目类别:
-
资助金额:$107.02万
-
财政年份:2010
-
负责人:Pamela B Davis
-
依托单位:
Case Western Researve Clinical and Translational Science Institute (UL1)
-
批准号:7901706
-
项目类别:
-
资助金额:$97.88万
-
财政年份:2009
-
负责人:Pamela B Davis
-
依托单位:
Nucleolin-mediated cell entry of DNA nanoparticles
-
批准号:7849651
-
项目类别:
-
资助金额:$23.55万
-
财政年份:2009
-
负责人:Pamela B Davis
-
依托单位:
CASE WESTERN RESERVE UNIVERSITY/CLEVELAND CLINIC CTSA (UL1): BPCA
-
批准号:7961847
-
项目类别:
-
资助金额:$47.8万
-
财政年份:2009
-
负责人:Pamela B Davis
-
依托单位:
Nucleolin-mediated cell entry of DNA nanoparticles
-
批准号:7701310
-
项目类别:
-
资助金额:$19.63万
-
财政年份:2009
-
负责人:Pamela B Davis
-
依托单位:
CASE WESTERN RESERVE UNIVERSITY/CLEVELAND CLINIC CTSA (UL1): BPCA
-
批准号:7961848
-
项目类别:
-
资助金额:$49.2万
-
财政年份:2009
-
负责人:Pamela B Davis
-
依托单位:
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
-
批准号:7719785
-
项目类别:
-
资助金额:$210.03万
-
财政年份:2008
-
负责人:Pamela B Davis
-
依托单位:
CASE WESTERN RESERVE UNIVERSITY/CLEVELAND CLINIC CTSA
-
批准号:7719787
-
项目类别:
-
资助金额:$420.04万
-
财政年份:2008
-
负责人:Pamela B Davis
-
依托单位:
国内基金
海外基金
登录
查看更多内容
微米和纳米塑料作用下2019-nCoV抗病毒药物利巴韦林对河蚬的毒性作用机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2021
-
负责人:郭晓宇
-
依托单位:
2019-nCoV感染导致人体淋巴细胞减低机制及其对机体免疫功能影响
-
批准号:82030002
-
项目类别:专项基金项目
-
资助金额:135万元
-
批准年份:2020
-
负责人:曹彬
-
依托单位:
基于人口流动大数据的新型冠状病毒(2019-nCoV)输出感染风险及接触网络传播模型研究
-
批准号:--
-
项目类别:--
-
资助金额:135万元
-
批准年份:2020
-
负责人:吕欣
-
依托单位:
云南驯养野生动物中新型冠状病毒(2019-nCoV)溯源调查与验证
-
批准号:--
-
项目类别:--
-
资助金额:140万元
-
批准年份:2020
-
负责人:夏雪山
-
依托单位:
新型冠状病毒(2019-nCoV)反向遗传系统及啮齿类感染模型的建立与应用
-
批准号:--
-
项目类别:--
-
资助金额:150万元
-
批准年份:2020
-
负责人:黄耀伟
-
依托单位:
血必净预防2019-nCoV肺炎发生ARDS及机制研究
-
批准号:82041003
-
项目类别:专项基金项目
-
资助金额:135万元
-
批准年份:2020
-
负责人:宋元林
-
依托单位:
新型冠状病毒2019-nCoV复制复合体关键蛋白的功能与潜在药物靶点研究
-
批准号:--
-
项目类别:专项基金项目
-
资助金额:150万元
-
批准年份:2020
-
负责人:郭德银
-
依托单位:
2019-nCoV蝙蝠及人群代表性流行株致病能力的比较研究
-
批准号:--
-
项目类别:专项基金项目
-
资助金额:150万元
-
批准年份:2020
-
负责人:周鹏
-
依托单位:
人新型冠状病毒2019-nCoV受体利用介导的种间传播和感染机制研究
-
批准号:--
-
项目类别:专项基金项目
-
资助金额:140万元
-
批准年份:2020
-
负责人:葛行义
-
依托单位:
2019-nCoV“不典型症状”感染者的宿主因素及其作用机制研究
-
批准号:--
-
项目类别:专项基金项目
-
资助金额:150万元
-
批准年份:2020
-
负责人:张文宏
-
依托单位: